MeSH tree: C15.378.463.515.460
Altum Sequencing, a start-up supported by the C3N-IA Science Park at Universidad Carlos III de Madrid (UC3M) and specialized in oncology, has developed a tool to monitor treatment response in patients with solid tumors from ...
Jun 19, 2025
0
33
Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk of developing multiple myeloma, the second most common type of blood cancer. The study showed that the diet was not ...
Jun 2, 2025
0
18
A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical Oncology (ASCO), held May 30 ...
May 30, 2025
0
32
A new risk assessment score developed by researchers at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, and Massachusetts General Hospital reveals how multiple myeloma, a form of blood cancer, begins ...
May 21, 2025
0
31
Personalized medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most promising tools. This innovative approach, which involves genetically modifying the cells of the immune system, is ...
May 20, 2025
0
23
An innovative blood cancer treatment regimen could extend remission by seven months on average, according to a clinical trial led by the University of Leeds.
May 15, 2025
0
23
How cancer patients relying on daratumumab feel physically before starting the therapy can predict how long they will live and how well they will respond to the anti-multiple myeloma (MM) drug, according to a new study published ...
May 14, 2025
0
16
Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal plasma cells accumulate, they crowd out healthy cells and cause symptoms such as bone pain and tiredness.
Apr 25, 2025
0
20
Annual whole-body, low-dose computed tomography (WBLDCT) can improve the management of smoldering multiple myeloma (SMM), according to a study published online March 25 in the Journal of Clinical Medicine.
Apr 22, 2025
0
11
Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment responses in multiple myeloma patients by blocking a protein that plays a key role in drug resistance. ...
Apr 15, 2025
0
16
